Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites

Br J Haematol. 2000 Nov;111(2):712-3. doi: 10.1046/j.1365-2141.2000.02357-2.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antineoplastic Agents, Alkylating / adverse effects
  • Drug Administration Schedule
  • Humans
  • Leukemia, Myeloid, Acute / chemically induced*
  • Male
  • Myelodysplastic Syndromes / chemically induced*
  • Neoplasms, Multiple Primary / drug therapy
  • Tegafur / adverse effects*
  • Time Factors
  • Uracil / adverse effects

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Alkylating
  • Tegafur
  • Uracil